Stat3 Rat shRNA Plasmid (Locus ID 25125)

SKU
TG709368
Stat3 - Rat, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
  $883.00
In Stock*
Specifications
Specifications
Product Data
Locus ID 25125
Synonyms MGC93551
Vector pGFP-V-RS
E. coli Selection Kanamycin
Mammalian Cell Selection Puromycin
Format Retroviral plasmids
Components Stat3 - Rat, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 25125). 5µg purified plasmid DNA per construct
29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free.
RefSeq NM_012747, NM_012747.1, NM_012747.2, BC087025
UniProt ID P52631
Summary transcription factor that plays a role in induction of gene expression during acute phase response RGD, Feb 2006
shRNA Design These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Storage Store at -20°C
Shipping Ambient
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

ß-cell mass restoration by α7-nicotinic acetylcholine receptor activation
Gupta, Lacayo, Greene et al
J. Biol. Chem. (2018) 293 (52), 20295-20306 DOI: 10.1074/jbc.RA118.004617
AI Summary: OriGene’s 29mer shRNA plasmids targeting rat STAT3 (catalog numbers GI737473 and GI737474) were used to establish stable STAT3 knockdown in INS-1 cells, enabling the study of STAT3’s role in β-cell survival and signaling pathways.
Snippet: Establishing stable knockdown of STAT3 in INS-1 cells: Four 29mer shRNA plasmids in a retroviral GFP vector (pGFP-V-RS) directed against rat STAT3 (Origene, GI737473: GTCCTCT ATCAGCACAACCTGCGAAGAAT;GI737474
STAT3-mediated CD133 upregulation contributes to promotion of hepatocellular carcinoma
Won, Kim, Hee Yi et al
Hepatology (2015)
Cited by 196
AI Summary: OriGene’s pLKO plasmid was used to construct lentiviral shRNA vectors for CD133 gene silencing, enabling the study of CD133’s role in hepatocellular carcinoma progression.
Snippet: All rights reserved. Page 8. HEP-14-2196.R2 8 shRNA preparation and plasmid construction. pLKO plasmid (OriGene, Rockvile, MD) was used for lentiviral DNA vector-based shRNA construction. Based on cDNA sequence of CD133 (GenBank accession No. ... Cite SaveSaving
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
Chung, Giehl, Wu et al
Int J Oncol (2014) 44 (2), 403-11 DOI: 10.3892/ijo.2013.2195
Cited by 163
AI Summary: In this study, OriGene products—specifically the STAT3 shRNA lentiviral particles and STAT3 antibody—were used to knock down STAT3 expression and detect STAT3 protein levels, respectively, thereby enabling the authors to investigate the role of STAT3 in promoting stem cell traits and drug resistance in HER2-overexpressing breast cancer cells.
FigureFigureFigure
Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells
Chung, Aroh, Vadgama
PLoS One (2013) 8 (12), e83971 DOI: 10.1371/journal.pone.0083971
Cited by 102
AI Summary: In this study, OriGene products—including STAT3 shRNA (TG311438), hTERT shRNA (TG311019), and CD44 shRNA (TG310939)—were used to specifically knock down STAT3, hTERT, and CD44 expression in human breast cancer cells, enabling the authors to elucidate the roles of these molecules in regulating stem cell-like traits and telomerase activity.
FigureFigureFigure
Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition
Ai, Liang, Lu et al
Cancer Biol. Ther. (2013) 14 (3), 237-45 DOI: 10.4161/cbt.23295
Cited by 39
AI Summary: OriGene products contributed to this study by providing STAT3 shRNA (shRNA1 and shRNA2), which were used to knock down STAT3 expression and investigate its role in Brk-mediated regulation of breast cancer cell survival and epithelial-to-mesenchymal transition.
Snippet: STAT3 shRNA (shRNA1 targeting sequence: GCTGACTACACTGGCAGAGAAACTCTTGG;shRNA2 targeting sequence: TGGCTGACTGGAAGAGGCGGCAACAGATT) were purchased from OriGene. ... the inserts and lower wells in 24-well cell culture plates (Corning Life Sciences
Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors
Manuel, Blache, Paquette et al
Cancer Res. (2011) 71 (12), 4183-91 DOI: 10.1158/0008-5472.CAN-10-4676
Cited by 16
AI Summary: OriGene's STAT3 shRNA constructs were used to silence STAT3 expression in melanoma cells, enabling the researchers to assess the impact of STAT3 knockdown on tumor immunosuppression and the efficacy of their cancer vaccine strategy.
Snippet: sseF gene. shRNA constructs against STAT3 (Origene) were tested for silencing by stable transfection of B16F10 cells followed by Western blot analysis using polyclonal rabbit antibody against STAT3 (Santa Cruz Biotech). The
Showing 1-6 of 6 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products